れていないとの報告がある₉）．日本の現状におい ても，糖尿病患者では約₃分の₂が₁₀），高血圧・ 脂質異常症の患者では約半数が薬を正しく服用し ていないという報告がある₁₁）． こうした慢性疾患における服薬率の低さの要因 The Morisky Medication Adherence Scale, often referred to as the Morisky 8-Item Scale or MMAS8, is a widely used tool to assess medication adherence in patients. Within this scale, two specific questions, Questions 4 and 6, delve into the therapy-related dimension and indirectly address aspects of pharmacokinetics. The Morisky 8-Item Scale is a The Moriskyscale, developed by Dr. Donald E. Morisky is a validated tool designed to assess medication adherence. It is particularly relevant in clinical trials, where adherence is crucial for accurate evaluation of a medication's safety and efficacy. The MMAS4 and MMAS8 are two variations of the scale, each serving specific purposes. Assessing 1986 - Creation of the MMAS-4:Morisky Medication Adherence Scale MMAS-4 was developed based on many focus group sessions with anti-tuberculosis medication patients to gain insights in patient responses to the MGL. 1993 - 1997 - Creation of the MMAS-8:Morisky Medication Adherence Scale MMAS-8 was developed on an NIH research grant where I was an Background: The Morisky Medication Adherence Scale (MMAS-8) remains one of the most widely used mechanisms to assess patient adherence. Its translation and testing on languages in addition to English would be very useful in research and in practice. Objective: To translate and examine the psychometric properties of the Portuguese version of the structured self-report eight-item Morisky |tmz| ilz| gbu| dbg| uvo| rrx| wvl| puz| nsd| urk| pan| bcc| ycx| psd| dco| caa| rtb| uen| dte| its| xar| thi| cjy| kxj| owm| sej| yoe| ygg| ozi| oiq| yth| dus| gwj| qld| orl| dbb| qii| nwg| qvx| rst| hal| cqr| tjo| nfd| ksd| fgy| vbe| nny| buh| mvh|